Efficacy and safety of clopidogrel only vs. clopidogrel added proton pump inhibitors in the treatment of patients with coronary heart disease after percutaneous coronary intervention: A systematic review and meta-analysis

BACKGROUND: Controversy still exists that whether clopidogrel should add proton pump inhibitors (PPIs) in patients with coronary heart disease after percutaneous coronary intervention (PCI). The aim of this study was to evaluate the efficacy and safety of clopidogrel added proton pump inhibitors (PP...

Descripción completa

Detalles Bibliográficos
Autores principales: Pang, Jun, Wu, Qiang, Zhang, Zheng, Zheng, Tong-zhang, Xiang, Qiuling, Zhang, Ping, Liu, Xiaoqiao, Zhang, Changhai, Tan, Hongwen, Huang, Jing, Liu, Wei, Song, Fang, Li, Zongzhuang, Yue, Feng, Jiang, Zhi, Wei, Fang, Zhou, Kai, Tang, Feng, Yang, Yongyao, Long, Xiangshu, Kuang, Chunyan, Wu, Yueting, Chen, Baolin, Tian, Ye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612751/
https://www.ncbi.nlm.nih.gov/pubmed/31321282
http://dx.doi.org/10.1016/j.ijcha.2018.12.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612751/
https://www.ncbi.nlm.nih.gov/pubmed/31321282
http://dx.doi.org/10.1016/j.ijcha.2018.12.016

Ejemplares similares